A new Lancet framework argues that cancer screening should match each person's risk. I agree, as long as precision also means doing less for people at low risk.

In June 2026, bioRxiv's parent openRxiv began testing an interactive way to read preprints. It is an experiment, and I think it asks the right question.

An AI system wrote a paper that cleared reviewers at an ICLR workshop. It is a real milestone, and an honest stress test of peer review itself.

A 2023 survey put numbers on the extra hours, rejections and skipped conferences that come with doing science in a second language. Journals and conferences can shrink that cost.